E
Kezar Life Sciences, Inc. KZR
$3.96 -$0.04-1.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -100.00% --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -100.00% --
Cost of Revenue -33.22% -27.92% -43.32% -29.18% -7.88%
Gross Profit 24.83% 19.56% 38.28% 22.18% 18.16%
SG&A Expenses -18.64% -17.01% -11.86% -9.04% 20.05%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -28.90% -25.46% -20.58% -7.61% 18.03%
Operating Income 23.90% 20.47% 15.30% 0.94% -10.27%
Income Before Tax 28.18% 22.40% 17.80% -9.10% -19.43%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 28.18% 22.40% 17.80% -9.10% -19.43%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 28.18% 22.40% 17.80% -9.10% -19.43%
EBIT 23.90% 20.47% 15.30% 0.94% -10.27%
EBITDA 24.09% 20.64% 15.43% 0.97% -10.57%
EPS Basic 8.00% 2.84% -1.56% -8.52% -18.68%
Normalized Basic EPS 0.21% -1.94% -6.59% 0.18% -9.45%
EPS Diluted 8.00% 2.84% -1.56% -8.52% -18.68%
Normalized Diluted EPS 0.21% -1.94% -6.59% 0.18% -9.45%
Average Basic Shares Outstanding 0.37% 0.41% 0.48% 0.57% 0.65%
Average Diluted Shares Outstanding 0.37% 0.41% 0.48% 0.57% 0.65%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --